AI tumor microenvironment analysis is becoming a major focus in precision oncology. New findings presented by Agenus and Noetik suggest artificial intelligence could improve patient selection for advanced immunotherapy treatments in metastatic colorectal cancer.
The retrospective study evaluated Noetik’s TARIO-2 platform in patients treated with botensilimab and balstilimab. Researchers analysed...
There is something deceptively understated about this AI-first C-suite transformation. Beneath the polished optimism of corporate press releases lies...